| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 02/02/2005 | EP1244610A4 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/01/2005 | US6849761 Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia |
| 02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849634 Potassium channel inhibitors |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | US20050020858 Reacting alkynylamine with substituted sulfonyl chloride, reacting product with substituted 2-iodophenylamine compound, cyclizing product to produce indole derivatives; inhibitors of cytosolic phospholipase A2 |
| 01/27/2005 | US20050020680 Hydroxyfattysulfonic acid analogs |
| 01/26/2005 | EP1117409B1 Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1570125A High purity soy bean isoflavone process using supercritical CO#-[2] extraction |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186331C Substituted 2, 4-diamino-1, 3, 5-triazines as herbicides |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/20/2005 | WO2005004897A1 Water-soluble shps as novel alkylating agents |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004802A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2004100282A3 Manufacture of a polymer device |
| 01/20/2005 | US20050014917 Used in electrochemical applications such as fuel cells, electrodialysis; separators; catalyst for Diels-Alder reactions; Friedel-Craft catalyst; fluoropolymers |
| 01/20/2005 | US20050014841 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529994A1 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/20/2005 | CA2525091A1 Water-soluble shps as novel alkylating agents |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497272A2 Method of preparing amine stereoisomers |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1496884A1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566085A Method for preparing chlorine sulfonyl isocyanic ester |
| 01/19/2005 | CN1566084A Novel optical pure water soluble diamine and derivative, preparation method and use thereof |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185108C Heat sensitive recording material |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6844366 Such as N-hydroxy-2(R)-((3,4-methylenedioxybenzyl)-(4-methoxy-2,3,6-trimethylbenzene-sulfonyl) amino)-3-methylbutyramide for treatment of diseases treatable with pro-collagen C-proteinase inhibitors |
| 01/13/2005 | WO2005003084A1 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
| 01/13/2005 | US20050009906 e.g., N-{4-[3-(4-Hydroxy-piperidin-1-yl)-3-oxo-propoxy]-cyclohexyl}-N-methyl-4-trifluoromethyl-benzenesulfonamide and p-chlorophenyl methyl-(2-{4-[methyl-(2-methylcarbamoyl-ethyl)-carbamoyl]-cyclohexyl}-ethyl)-carbamate |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | CA2533547A1 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564810A Method for producing arylsuphonic acid isocyanates |
| 01/11/2005 | US6841638 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000797A1 Process for preparing acylsulfamoylbenzamides |
| 01/06/2005 | WO2005000795A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2004071388A3 Medicinal compounds |
| 01/06/2005 | US20050004398 Reacting enantiomorph with acid and releasing; separation; crystallization; cardiovascular disorders |
| 01/06/2005 | US20050004372 Chlorination a a benzenesulfamoyl compound in presence of a base |
| 01/06/2005 | US20050004369 Phenyl substituted carboxylic acids |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050004043 Protease inhibitors; human t-cell leukemia virus; aids |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561326A Alpha-haloenamine reagents |
| 01/05/2005 | CN1560032A Sultonyl (thio)urea derivants, their preparation process and pharmaceutical composition containing them |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/02/2005 | WO2006125451A1 Hydroxyalkylamides |
| 01/02/2005 | CA2530195A1 Hydroxyalkylamides |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/30/2004 | US20040266718 Inhibition of specific histone deacetylase isoforms |
| 12/29/2004 | WO2004113280A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004113279A1 Inhibitors of matrix metalloproteinase |
| 12/29/2004 | WO2004113278A2 Acylsulfamide inhibitors of factor viia |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113273A1 Pesticidally active ketone and oxime derivatives |
| 12/29/2004 | WO2004113258A1 Carbon-carbon bond forming reaction |
| 12/29/2004 | WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |